Patents by Inventor Emerson Giovanelli

Emerson Giovanelli has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ENHANCED AFFINITY LIGANDS
    Publication number: 20190153171
    Abstract: The present invention relates to ligands, nanocrystal complexed with said ligands and their use for bio-imaging.
    Type: Application
    Filed: January 29, 2019
    Publication date: May 23, 2019
    Inventors: Nicolas LEQUEUX, Thomas PONS, Emerson GIOVANELLI, Edgar CAO, Marie-Laurence BARON-NIEL, Robin FAIDEAU
  • Enhanced affinity ligands
    Patent number: 10233291
    Abstract: The present invention relates to ligands, nanocrystal complexed with the ligands and their use for bio-imaging.
    Type: Grant
    Filed: June 7, 2013
    Date of Patent: March 19, 2019
    Assignees: NEXDOT, FONDS DE L'ESPCI-GEORGES CHARPAK
    Inventors: Nicolas Lequeux, Thomas Pons, Emerson Giovanelli
  • ENHANCED AFFINITY LIGANDS
    Publication number: 20150183939
    Abstract: The present invention relates to ligands, nanocrystal complexed with the ligands and their use for bio-imaging.
    Type: Application
    Filed: June 7, 2013
    Publication date: July 2, 2015
    Applicants: FONDS DE L'ESPCI - GEORGES CHARPAK, NEXDOT
    Inventors: Nicolas Lequeux, Thomas Pons, Emerson Giovanelli
  • Fluorinated catharanthine derivatives, their preparation and their utilisation as dimeric alkaloid precursors
    Patent number: 8101748
    Abstract: The fluorinated derivatives of catharanthine according to the invention respond to the general formula I: in which: the dotted line expresses the possibility of the presence of a double bond when the substitution —X is absent or else a single bond when —X designates a substitution for a group: H, OR, NR?R?, SR, or a halogen atom with R, R? and R? designating independently of one another a hydrogen atom or a linear or branched alkyl group in C1 to C6, R1, R2 and R3 represent independently of one another an atom of hydrogen, of fluorine or a methylated group, on the condition nevertheless that at least one of the radicals R1 and R2 represents an atom of fluorine, and n=1 or 2.
    Type: Grant
    Filed: September 20, 2007
    Date of Patent: January 24, 2012
    Assignees: Pierre Fabre Medicament, Commissariat a l'Energie Atomique
    Inventors: Lionel Moisan, Sébastien Comesse, Emerson Giovanelli, Bernard Rousseau, Eric Doris, Paul Hellier
  • FLUORINATED CATHARANTHINE DERIVATIVES, THEIR PREPARATION AND THEIR UTILISATION AS VINCA DIMERIC ALKALOID PRECURSORS
    Publication number: 20100093997
    Abstract: The fluorinated derivatives of catharanthine according to the invention respond to the general formula I: in which: the dotted line expresses the possibility of the presence of a double bond when the substitution —X is absent or else a single bond when —X designates a substitution for a group: H, OR, NR?R?, SR, or a halogen atom with R, R? and R? designating independently of one another a hydrogen atom or a linear or branched alkyl group in C1 to C6, R1, R2 and R3 represent independently of one another an atom of hydrogen, of fluorine or a methylated group, on the condition nevertheless that at least one of the radicals R1 and R2 represents an atom of fluorine, and n=1 or 2.
    Type: Application
    Filed: September 20, 2007
    Publication date: April 15, 2010
    Applicants: Pierre Fabre Medicament, COMMISSARIAT A L'ENERGIE ATOMIQUE
    Inventors: Lionel Moisan, Sébastien Comesse, Emerson Giovanelli, Bernard Rousseau, Eric Doris, Paul Hellier